Healthcare >> CEO Interviews >> June 23, 2008

Joseph M. Cummins – Amarillo Biosciences, Inc. (amar)

TWST: May we start with a short history and overview of your company?

Dr. Cummins: We are a public company with an interferon that we are developing

for oral applications in animals and